Enables Bristol Myers Squibb to expand its manufacturing capacity, meeting the growing demand for its range of cell therapies through Cellares’ platform.
Margrethe Sørgaard offers 25 years’ experience in leading positions in clinical development and operation, medical affairs and drug safety/pharmacovigilance.
New joint venture aims to cover the entire drug discovery process, spanning early drug discovery research through the inception of drug discovery startups.